Pages that link to "Q42493841"

The following pages link to Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor (Q42493841):

Displaying 48 items.

• PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer (Q21328702) (← links)
• The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene (Q24309577) (← links)
• 17beta-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptor (Q24792340) (← links)
• Targeting insulin and insulin-like growth factor signaling in breast cancer (Q26826380) (← links)
• Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects (Q28365959) (← links)
• Diabetes and cancer: Associations, mechanisms, and implications for medical practice (Q33759863) (← links)
• Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer (Q33842800) (← links)
• The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands (Q33904081) (← links)
• Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo (Q33918953) (← links)
• Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity (Q34070890) (← links)
• The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing (Q34150795) (← links)
• Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell lines (Q34406479) (← links)
• Acromegaly: re-thinking the cancer risk (Q34729995) (← links)
• The role of endocrine insulin-like growth factor-I and insulin in breast cancer (Q34888096) (← links)
• Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer (Q35048307) (← links)
• The insulin-like growth factor family of ligands, receptors, and binding proteins (Q35343968) (← links)
• Interference of the IGF system as a strategy to inhibit breast cancer growth (Q35465033) (← links)
• Type 1 IGF receptor in human breast diseases (Q35465137) (← links)
• Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells (Q35465155) (← links)
• Tamoxifen reduces serum insulin-like growth factor I (IGF-I) (Q35465195) (← links)
• Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma (Q35609719) (← links)
• Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. (Q35667940) (← links)
• Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis (Q35994133) (← links)
• Zinc and cancer: implications for LIV-1 in breast cancer (Q36126413) (← links)
• Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up (Q36295053) (← links)
• Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line (Q36618874) (← links)
• A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor (Q36656841) (← links)
• Effects of exercise training on inflammatory markers in patients with heart failure (Q36964526) (← links)
• Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody (Q37165350) (← links)
• Generation of a Conditionally Transformed Murine Embryonic Fibroblast Cell Line Using Doxycycline-Dependent IGF-1R Overexpression (Q39457320) (← links)
• Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes (Q39871445) (← links)
• Receptor guided 3D-QSAR: a useful approach for designing of IGF-1R inhibitors (Q40106980) (← links)
• Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. (Q40219858) (← links)
• Molecular and Cellular Aspects of Insulin-like Growth Factor Action (Q40393697) (← links)
• Regulation of insulin-like growth factors by antiestrogen (Q40395035) (← links)
• The insulin-like growth factor system as a target in breast cancer (Q40396511) (← links)
• William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms (Q40790197) (← links)
• Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated? (Q41062519) (← links)
• Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis (Q41554657) (← links)
• Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar (Q41654286) (← links)
• Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors (Q41687861) (← links)
• Identification of insulin-like growth factor binding proteins in breast cancer cells (Q41693934) (← links)
• Polyamine involvement in the secretion and action of TGF-alpha in hormone sensitive human breast cancer cells in culture (Q41790658) (← links)
• IGF‐I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3‐E1 osteoblastic cells (Q44660143) (← links)
• IGF and insulin receptor signaling in breast cancer. (Q46240548) (← links)
• Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotide (Q51518444) (← links)
• Insulin-like growth factors and cancer (Q67487325) (← links)
• The effects of TGF-alpha and 17 beta-estradiol on polyphosphoinositide metabolism in MCF-7 breast cancer cells (Q67507898) (← links)